QuintilesIMS Blog

Fresh ideas and insights from our experts around the globe

Brazilians flock to pharmacies: How healthcare companies can bolster sales by embracing this shifting shopper trend
Filtered by 'Biopharma' ×
A new QuintilesIMS Institute report explores the steady growth of drug expenditure in five developed countries, and what is driving these trends.
Read More
John Procter
Medical science liaisons provide a bridge between drug development and external stakeholders, meaning they are in an ideal situation to capture valuable scientific insights.
Read More
Andy Tisman
How wellness trends and emerging markets growth are boosting sales in over-the-counter products.
Read More
Sarah Rickwood
What it takes to thrive in an increasingly specialized marketplace.
Read More
Olga Uspenskaya-Cadoz
Tau imaging and predictive analytics take center stage at the annual event held by the Alzheimer’s Association.
Read More
Deep Patel
The growing need to treat and prevent AD is spurring new research, but healthcare industry stakeholders need to work collaboratively if we are going to successfully bring groundbreaking treatments to market.
Read More
Lisa Marie Saldanha
This is the first in a series of blogs about new models to improve collaborative academic research efficiency and increase its probability of success.
Read More
Susan Abedi
Susan Harris
Providing patients with materials about their condition and treatment options helps drive clinical trial recruitment and retention, as well as adherence to prescribed medications.
Read More
Penny Randall
How an Alzheimer’s disease study demonstrated the economic, scientific, and social benefits of telemedicine to clinical research.
Read More